Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Shinsei Bank poison pill defence wins backing of another proxy adviser

Published 11/07/2021, 09:00 PM
Updated 11/08/2021, 12:15 AM
© Reuters. FILE PHOTO: The Shinsei Bank logo is pictured at the lobby of the bank in Tokyo October 22, 2010. REUTERS/Yuriko Nakao
JP225
-

By Makiko Yamazaki

TOKYO (Reuters) -Proxy advisory firm ISS followed rival Glass Lewis & Co in recommending shareholders of Japan's Shinsei Bank Ltd vote for the lender's plan for a poison pill defence against an unsolicited $1.1 billion bid from SBI Holdings Inc.

In a report dated Nov. 7, ISS said the takeover defence was warranted partly because SBI has failed "to present specific plans to be implemented once it controls Shinsei Bank, causing uncertainty for shareholders."

ISS, formally Institutional Shareholder Services Inc, also pointed out that SBI's partial offer would leave shareholders unable to tender "in a position of minority shareholders of a listed company, whose liquidity will be significantly low."

Recommendations from ISS and Glass Lewis typically impact how foreign investors vote. Such investors account for nearly 30% of Shinsei's registered shareholders.

Mid-sized bank Shinsei opposed SBI's approach last month, saying that the offer could hurt interests of minority shareholders and that the price was too low. SBI, which owns an online brokerage and a bank, holds around 20% of Shinsei and wants to raise that to up to 48%.

Shinsei Bank "appears to try to leverage the pill as a tool of negotiation with SBI Holdings to extract better terms by attaching two reasonable conditions, from which shareholders should benefit," ISS said.

SBI declined to comment on the ISS report.

The online financial conglomerate, which has said it can overhaul the mid-sized lender, has promised to make every effort to repay the 350 billion yen ($3.09 billion) in public money Shinsei received during a banking crisis two decades ago.

ISS said SBI's business plan is not specific.

On Friday, Glass Lewis said SBI has provided "no measurable alternative to the status quo".

The focus is now on how the government, which owns about 20% of Shinsei, will vote on the poison pill at the shareholders meeting on Nov. 25, which needs a 50% majority to pass. Government sources said it hasn't decided yet.

The SBI-Shinsei battle comes at a time Japan is witnessing a rise in hostile takeovers. But investors are also watching to see if, under a new prime minister, it will roll back some pro-market policies.

© Reuters. FILE PHOTO: The Shinsei Bank logo is pictured at the lobby of the bank in Tokyo October 22, 2010. REUTERS/Yuriko Nakao

Shinsei's shares were down 2.4% in Monday afternoon trading, compared with a 0.25% decline in the benchmark Nikkei index.

($1 = 113.3500 yen)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.